CAV1 and lung carcinoma: Current data shows that CAV-1 gene disruption by using the CRISPR/Cas9 system can revert lung cancer cells’ resistance to radiation which suggests the potential of this technology to overcome the nonsmall cell lung cancer cell radio resistance and make the cells more responsive to radiation chemotherapy.